Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor

Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor

Item
http://www.wikidata.org/entity/Q41424778
Why human lifespan is rapidly increasing: solving "longevity riddle" with "revealed-slow-aging" hypothesis.Azithromycin suppresses CD4(+) T-cell activation by direct modulation of mTOR activity.Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to.Macrophage autophagy in atherosclerosis.Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorderDysregulation of the Low-Density Lipoprotein Receptor Pathway Is Involved in Lipid Disorder-Mediated Organ Injury.Management of multicellular senescence and oxidative stress.Progeria, rapamycin and normal aging: recent breakthrough.Potential therapeutic effects of mTOR inhibition in atherosclerosis.mTOR drives cerebral blood flow and memory deficits in LDLR(-/-) mice modeling atherosclerosis and vascular cognitive impairment.Autophagy links inflammasomes to atherosclerotic progression.AMP-activated protein kinase α1 promotes atherogenesis by increasing monocyte-to-macrophage differentiation.Defective Protein Catabolism in Atherosclerotic Vascular Inflammation.Rapamycin inhibits ox-LDL-induced inflammation in human endothelial cells in vitro by inhibiting the mTORC2/PKC/c-Fos pathway.Multiple noncovalent interactions mediated one-pot therapeutic assemblies for the effective treatment of atherosclerosis
P2860

Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor

Item
http://www.wikidata.org/entity/Q41424778
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Low-dose oral sirolimus reduce ...... mice lacking the LDL receptor
@en
type
label
Low-dose oral sirolimus reduce ...... mice lacking the LDL receptor
@en
prefLabel
Low-dose oral sirolimus reduce ...... mice lacking the LDL receptor
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Low-dose oral sirolimus reduce ...... mice lacking the LDL receptor
@en
P2093
P2860
P304
P31
P356
10.1111/J.1476-5381.2008.00080.X
P407
P433
P478
P577
P5875
P698
P932